Clinical Trials Directory

Trials / Completed

CompletedNCT04408001

Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff

Status
Completed
Phase
Study type
Observational
Enrollment
499 (actual)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

COVID-19 is a pathology linked to the SARS-CoV-2 virus, a new virus of the coronaviridae family that emerged in China in December 2019 before rapidly becoming a pandemic according to the WHO on March 11, 2020. The epidemic affected France from February 2020. On February 24, a patient hospitalized at Percy hospital was the cause of a major nosocomial epidemic, potentially responsible for more than 250 symptomatic people in the hospital as of April 6. The outbreak was identified by Percy hospital management on March 16, and barrier measures were immediately put in place. From March 20, a mixed investigation unit set up a chain of nasopharyngeal swabs for Percy hospital staff. A COVID-19 case reporting unit was set up at Percy hospital in response to the identification of the outbreak within the hospital. This unit carried out rapid identification and regular follow-up until the return to work of the staff. Thus all symptomatic patients are identified and the COVID-19 case census cell will follow all Percy hospital staff, including volunteers recruited to deal with the epidemic, throughout the duration of the epidemic. This population, captive by nature, will be one of the few described in the world during this epidemic. Current data on short-, medium- and long-term immunity induced by COVID-19 infection are fragmentary, as is the existence of a large asymptomatic population, making it difficult to cut the chains of transmission in the absence of an effective diagnostic tool. Another important issue is the quality of immunity induced by the infection, as it conditions the future of the pandemic, which could become endemic and recurrent if immunity were not sterilizing. As yet unpublished data in primates show that in the primate model re-infection is not possible in the short term, while patients cured from the Wuhan epidemic seem to be detected again positive for virus shedding. The objective of this study is to characterize the immunity (systemic and local) induced by SARS-Cov-2 infection among Percy hospital staff who are at high risk of contamination even in a period of confinement.

Conditions

Interventions

TypeNameDescription
OTHERClinical interviewAt each study visit, participants will be questioned by a physician about their persistent symptoms or the existence of intercurrent infections that may resemble COVID-19.
BIOLOGICALBlood collectionAt each study visit, * 1 EDTA tube for complete blood count * 3 dry tubes with gel for serology, serum neutralisation test and serum library * 1 cell preparation tube for the separation of immune cells within the circulating blood will be collected.
BIOLOGICALSaliva collectionAt each study visit, a saliva sample will be collected for the determination of IgA antibodies.

Timeline

Start date
2020-06-04
Primary completion
2022-03-15
Completion
2022-03-15
First posted
2020-05-29
Last updated
2023-04-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04408001. Inclusion in this directory is not an endorsement.